Saxenda vs Wegovy: Which One Wins in 2026?

Saxenda at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2014
• Route: subcutaneous injection (multi-dose pen)
• Typical frequency: once daily
• Half-life: approximately 13 hours
• Cash price (US): $1,200-$1,400/month without insurance
• Receptor target: GLP-1 receptor

Saxenda comparison pages tend to overstate the differences. The honest take is that most well-established options in this space are similar enough that insurance coverage, prescriber familiarity, and personal preference matter more than head-to-head efficacy.

Mechanism

Saxenda: Saxenda is liraglutide dosed for weight management. The same GLP-1 receptor agonist used for diabetes (Victoza) but titrated to a higher 3.0 mg/day target dose.

Wegovy: Wegovy is semaglutide labeled and dosed for weight loss. It targets the same GLP-1 receptor pathways as Ozempic but at a higher target dose (2.4 mg weekly) to maximize appetite suppression and weight reduction.

For people new to this comparison, the practical takeaway is that both work through similar pathways but have different pharmacokinetics.

Dosing & Administration

Effectiveness

Saxenda: Mean weight loss of 8% of body weight at 56 weeks in SCALE trials — modest compared with semaglutide or tirzepatide.

Wegovy: Mean weight loss of 14.9% of body weight at 68 weeks in STEP 1 (vs 2.4% on placebo). Cardiovascular benefit demonstrated in SELECT.

In head-to-head comparisons (where they exist), the higher-dose newer agents tend to outperform older ones — sometimes meaningfully. Reference trials: SCALE Obesity (Pi-Sunyer 2015, NEJM) — 9 for Saxenda; STEP 1 (Wilding 2021, NEJM) — 14 for Wegovy.

Side Effects

The two compounds have overlapping side-effect profiles. Common to both:

• nausea
• diarrhea
• constipation
• vomiting
• headache
• injection-site reactions

Important risks worth knowing for both:

• pancreatitis
• gallbladder disease
• thyroid C-cell tumors (boxed warning)
• acute kidney injury

Cost

Saxenda: $1,200-$1,400/month without insurance. Wegovy: $1,300-$1,400/month without insurance.

Insurance coverage and manufacturer programs change the relative cost picture significantly. See our individual cost guides for Saxenda cost and Wegovy cost for the latest numbers.

Which Is Right for You?

The practical decision usually comes down to four factors:

1. What's covered by your insurance? Often the deciding factor
2. What does your prescriber have experience with? Familiarity reduces dosing errors
3. How comfortable are you with injections (or oral dosing if applicable)?
4. What's your tolerance for side effects?

If you and your clinician end up split between Saxenda and Wegovy, either is a defensible choice in most cases.

Switching Between Them

Switching from Saxenda to Wegovy (or the reverse) is usually straightforward but should be done with clinician guidance — particularly to align dose escalation and avoid GI side effects from re-titration.

Bottom Line

Don't overthink the Saxenda vs alternative decision. Both produce results; the difference is usually smaller than the discussion implies.

Frequently Asked Questions

Related Reading

• Saxenda Explained: How It Works and Who It's For
• Saxenda Side Effects Decoded: What's Normal vs. What Isn't
• Does Saxenda Really Work? An Evidence-Based Results Review
• Saxenda Price Decoded: Insurance, Coupons, and Cash-Pay Options
• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile

Sources

• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.
• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.
• Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). NEJM 2015;373:11.

This page is informational only and is not a personalized recommendation. The right choice depends on your individual situation.